Search

Author/Creator Park, K. T.

1. A population physiologically‐based pharmacokinetic model to characterize antibody disposition in pediatrics and evaluation of the model using infliximab. Issue 1 (19th July 2021)

Authors:
Chang, Hsuan Ping; Shakhnovich, Valentina; Frymoyer, Adam; Funk, Ryan Sol; Becker, Mara L.; Park, K. T.; Shah, Dhaval K.
Other Names:
Magavern Emma guestEditor.; Piasecki Jan guestEditor.; Cremers Serge guestEditor.; Cohen Adam guestEditor.
Journal:
British journal of clinical pharmacology
Issue:
Volume 88:Issue 1(2022)
Page Start:
290
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Implementable Strategies and Exploratory Considerations to Reduce Costs Associated with Anti-TNF Therapy in Inflammatory Bowel Disease. Issue 5 (21st January 2014)

Authors:
Park, K. T.; Crandall, Wallace V.; Fridge, Jacqueline; Leibowitz, Ian H.; Tsou, Marc; Dykes, Dana M. H.; Hoffenberg, Edward J.; Kappelman, Michael D.; Colletti, Richard B.
Journal:
Inflammatory bowel diseases
Issue:
Volume 20:Issue 5(2014)
Page Start:
946
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Out-of-pocket Cost Burden in Pediatric Inflammatory Bowel Disease: A Cross-sectional Cohort Analysis. Issue 6 (June 2015)

Authors:
Sin, Aaron T.; Damman, Jennifer L.; Ziring, David A.; Gleghorn, Elizabeth E.; Garcia-Careaga, Manuel G.; Gugig, Roberto R.; Hunter, Anna K.; Burgis, Jennifer C.; Bass, Dorsey M.; Park, K. T.
Journal:
Inflammatory bowel diseases
Issue:
Volume 21:Issue 6(2015:Jun.)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗